Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates

Author：                                

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.3, 2012-01, pp. : 825-832

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DNA methylation as a biomarker in breast cancer

By Martens John WM   Margossian Astrid L   Schmitt Manfred   Foekens John   Harbeck Nadia  

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1245-1256

Future Medicine

Access to resources Recommend Favorite

DNA methylation as an epigenetic biomarker in colorectal cancer

By              

Oncology Letters, Vol. 6, Iss. 6, 2013-01 ,pp. : 1687-1692

Spandidos Publications

Access to resources Recommend Favorite

Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions

By            

Oncology Reports, Vol. 32, Iss. 4, 2014-01 ,pp. : 1435-1440

Spandidos Publications

Access to resources Recommend Favorite

Methylation of the RASSF1A and RARβ genes as a candidate biomarker for lung cancer

By            

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 1067-1071

Spandidos Publications

Access to resources Recommend Favorite

Autoantibodies against insulin-like growth factorbinding protein-2 as a serological biomarker in the diagnosis of lung cancer

By                

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 93-100

Spandidos Publications

Access to resources Recommend Favorite